Liofilchem has received clearance from the FDA to market in the United States the MTS™ (MIC Test Strip) Penicillin G, a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of Penicillin G against Streptococcus pneumoniae, Streptococcus pyogenes (Group A), Streptococcus dysgalactiae (Group C & G), Streptococcus anginosus (Group C & G), Streptococcus constellatus (Group C & G), Streptococcus intermedius (Group C & G).

More technical details on the Penicillin G MIC Test Strip IFU

MTS™ (MIC Test Strips) are porous strips with special features (International Patent) that are impregnated with a predefined concentration gradient of antibiotic, across 15 two-fold dilutions of a conventional MIC method. On one side of the strip there is a printed MIC scale in μg/mL and a code that identifies the antimicrobial agent.

MTS™ Penicillin G 0.002-32 μg/mL

• 10 strip pack: ref. 921031
• 30 strip pack: ref. 92103
• 100 strip pack: ref. 921030

Penicillin G is the most recent FDA approved item in the MTS™ (MIC Test Strip) product range, following approvals of 

• Vancomycin
• Dalbavancin
• Ceftolozane-tazobactam
• Meropenem
• Ceftazidime
• Telavancin
• Tedizolid
• Delafloxacin
• Clindamycin
• Erythromycin
• Linezolid 
• Meropenem-vaborbactam 
• Azithromycin
• Ceftazidime-avibactam 
• Plazomicin

strips. In the meantime, the rest of the MTS™ range is available in the United States as research use only devices, while the entire MTS™ product catalog is CE marked and fully available as IVD for clinical diagnostics purposes in Europe and approved in Canada by Health Canada.  MTS™ is also registered at the competent Authority in many countries outside Europe as a clinical diagnostic device.

The current MTS™ range comprises antibiotics, antifungals, antimycobacterials, and combined strips for detection of resistance mechanisms (ESBL, MBL, KPC, AmpC and GRD) for over 150 items.